Venture capitals play a major role in providing financial support to startup companies through strategic investments/men...
Japanese firm Daiichi Sankyo Company has launched DELYTACT® (teserpaturev/G47∆), an oncolytic virus developed ...
Japanese firm Takeda Pharmaceutical has announced the exercise of its option to acquire UK-based GammaDelta Therape...
A team of scientists at the Center for iPS Cell Research and Application (CiRA), Kyoto University in Japan, has sho...
Daiichi Sankyo has announced the progress of development of DS-5670, an mRNA vaccine in Japan, being evaluated against t...
Tokai University, Toyohashi University of Technology, Chubu University, and DENSO Corporation in Japan have been develop...
Aichi Cancer Center and Fujitsu have announced the development of an artificial intelligence (AI) based solution ab...
Japanese firm Sumitomo Dainippon Pharma and US-based BehaVR, Inc. have signed definitive agreements to develop and ...
A team of researchers at the Institute for the Advanced Study of Human Biology (ASHBi) at Kyoto University, Japan&n...
A research team from Tokyo Medical and Dental University and Keio University in Japan combined a finger motion analysis ...
Japan's Shimadzu Corporation collaborated with Drs William Redmond and Yoshinobu Koguchi of the Providence Cancer Instit...
Fujitsu Limited has started joint clinical research with the University of Tokyo Hospital to verify the effectiveness of...
The 6,000 square-meter site will provide flexible clinical supply solutions, serving both local and global biotech and p...
A previously unknown virus that can infect humans and cause disease has been identified by scientists in Japan. The nove...
Japan-based Olympus Corporation is establishing Olympus Innovation Ventures, LLC as a corporate venture capital fund. I...
CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summi...
Japan-based FUJIFILM Corporation has reached agreement on core terms with Australian regenerative medicine venture Cynat...
Japanese firms Takeda Pharmaceutical Company and JCR Pharmaceuticals have announced a geographically-focused exclusive c...
To make the trial investments more meaningful and to avoid ambivalence in animal models, medical science is adopting nov...
US-based AgNovos Healthcare and Japanese firm Asahi Kasei Pharma Corporation have entered into an exclusive option agree...
UK-based Aptamer Group and BizCom Japan, Inc., a Japan-based trading and consultancy company, have entered into a distri...
Astellas Pharma Inc. and Seagen Inc. announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved P...
Swiss firm Vifor Fresenius Medical Care Renal Pharma (VFMCRP) has announced that Japan’s Ministry of Health and La...
Japanese firm Takeda Pharmaceutical has announced the addition of four partnerships to its Global Corporate So...
US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...
